259 results on '"Leung, Gary"'
Search Results
2. Improving Semantic Segmentation in Transformers using Hierarchical Inter-Level Attention
3. VASTA: A Vision and Language-assisted Smartphone Task Automation System
4. First evidence of the incorporation of daprodustat and other hypoxia-inducible factor stabilizers into equine hair by passive transfer based on segmental quantitative analysis
5. Generic approach for the discovery of drug metabolites in horses based on data-dependent acquisition by liquid chromatography high-resolution mass spectrometry and its applications to pharmacokinetic study of daprodustat
6. FRI-435 Serological and nucleic acid testing laboratory screening rates for hepatitis delta virus among adult patients in the United States
7. Comprehensive metabolic study of nicotine in equine plasma and urine using liquid chromatography/high-resolution mass spectrometry for the identification of unique biomarkers for doping control
8. Broad‐spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high‐resolution mass spectrometry.
9. Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy
10. Counteracting Packet Loss in Fingerprint-based Indoor Positioning via Spatially Regularized Entropy and Ground-truth Prior Variational Inference
11. A Broad-Spectrum Peptide Screening Method Using an Optimized Solid-Phase Extraction and Liquid Chromatography–High-Field Asymmetric Ion Mobility Spectrometry–Mass Spectrometry for Doping Control in Equine Urine
12. Pharmacokinetic study of osilodrostat and identification of mono‐hydroxylated metabolite in equine plasma for the purpose of doping control.
13. Deep Learning‐Based Bluetooth Low‐Energy 5.1 Multianchor Indoor Positioning with Attentional Data Filtering.
14. Evaluation of plasma and urine pharmacokinetics of tranexamic acid for equine medication control.
15. Evaluation of plasma and urine pharmacokinetics of tranexamic acid for equine medication control
16. Healthcare resource use and costs associated with hepatitis delta virus infection compared to hepatitis B virus monoinfection among commercially insured patients in the US
17. Significantly higher clinical and economic burden following diagnosis of hepatitis delta virus infection among commercially insured adults with chronic hepatitis B in the United States
18. Hepatitis delta treatment utilization in the United States: an analysis of commercially insured adults with hepatitis delta virus infection
19. Increased baseline comorbidity burden among commercially insured patients with hepatitis delta virus infection vs hepatitis B virus monoinfection in the United States
20. Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control
21. Segmental analysis and long-term monitoring of vadadustat in equine hair for the purpose of doping control.
22. Update on Dental Luting Materials
23. Race & Nationality Adult Pilot
24. Assimilationist policies and the support for authoritarian rule
25. What does it mean to be Chinese
26. Additional studies on nicotine exposure in horses: Accurate quantification and elimination profiles of potential biomarkers in plasma and urine
27. Pharmacokinetic Study of Vadadustat and High-Resolution Mass Spectrometric Characterization of its Novel Metabolites in Equines for the Purpose of Doping Control
28. Automatic estimation of the first three subglottal resonances from adults’ speech signals with application to speaker height estimation
29. Long‐term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometry for the purpose of doping control
30. Identification of potential biomarkers in urine and plasma after consumption of tobacco product in horses
31. Twelve-Month Diagnosed Prevalence of Behavioral Health Disorders Among Elderly Medicare and Medicaid Members
32. Factors associated with Medicaid patients' access to buprenorphine treatment
33. A Retrospective Database Analysis of Treatment Pathways in US Medicare Patients with Multiple Myeloma and Prior Exposure to Daratumumab, an Immunomodulatory Agent, and a Proteasome Inhibitor
34. A Retrospective Database Analysis of Treatment Pathways in US Medicare Patients with Multiple Myeloma Following Sequential Treatment with Lenalidomide and a Proteasome Inhibitor
35. Comprehensive metabolic study of IOX4 in equine urine and plasma using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometer for the purpose of doping control
36. Screening of drugs in equine plasma using automated on-line solid-phase extraction coupled with liquid chromatography–tandem mass spectrometry
37. Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography–mass spectrometry
38. Establishment of a post‐race biomarkers database and application of pathway analysis to identify potential biomarkers in post‐race equine plasma
39. DIRECT ORAL ANTICOAGULANTS AND WARFARIN: EFFECTIVENESS AND SAFETY OUTCOMES AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH MULTIMORBIDITY
40. EFFECTIVENESS AND SAFETY OF DIRECT ORAL ANTICOAGULANTS AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH MULTIMORBIDITY
41. Establishment of a post‐race biomarkers database and application of pathway analysis to identify potential biomarkers in post‐race equine plasma.
42. Metabolic study of GW1516 in equine urine using liquid chromatography/electrospray ionization Q‐Exactive high‐resolution mass spectrometry for doping control
43. WED-200 - Significantly higher clinical and economic burden following diagnosis of hepatitis delta virus infection among commercially insured adults with chronic hepatitis B in the United States
44. WED-160 - Healthcare resource use and costs associated with hepatitis delta virus infection compared to hepatitis B virus monoinfection among commercially insured patients in the US
45. WED-153 - Increased baseline comorbidity burden among commercially insured patients with hepatitis delta virus infection vs hepatitis B virus monoinfection in the United States
46. WED-134 - Hepatitis delta treatment utilization in the United States: an analysis of commercially insured adults with hepatitis delta virus infection
47. A bottom-up approach in estimating the measurement uncertainty and other important considerations for quantitative analyses in drug testing for horses
48. High throughput screening of sub-ppb levels of basic drugs in equine plasma by liquid chromatography–tandem mass spectrometry
49. Metabolic studies of mesterolone in horses
50. Observe and be guarded: the development and rupture of an abdominal aortic mycotic aneurysm in an afebrile hemodialysis patient with normal angiogram, and CT scan, and sterile blood cultures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.